Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16944535rdf:typepubmed:Citationlld:pubmed
pubmed-article:16944535lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0019638lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1550594lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1412282lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1548760lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1547300lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0580822lld:lifeskim
pubmed-article:16944535lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:16944535pubmed:issue7lld:pubmed
pubmed-article:16944535pubmed:dateCreated2006-10-2lld:pubmed
pubmed-article:16944535pubmed:abstractTextLysophosphatidic acid acyltransferase-beta (LPAAT-beta) tumor expression is an emerging prognostic, diagnostic, and therapeutic target in early epithelial ovarian cancer (EOC). The significance of tumor overexpression of LPAAT-beta was investigated in a large number of advanced- and early-stage EOC patients.lld:pubmed
pubmed-article:16944535pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16944535pubmed:languageenglld:pubmed
pubmed-article:16944535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16944535pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16944535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16944535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16944535pubmed:statusMEDLINElld:pubmed
pubmed-article:16944535pubmed:monthOctlld:pubmed
pubmed-article:16944535pubmed:issn0008-543Xlld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:SoslowRobert...lld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:BarakatRichar...lld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:AghajanianCar...lld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:SingerJackJlld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:HedvatCyrusClld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:DupontJakobJlld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:BonhamLynnLlld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:LinkovIrinaIlld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:IasonosAlexia...lld:pubmed
pubmed-article:16944535pubmed:authorpubmed-author:DiefenbachCat...lld:pubmed
pubmed-article:16944535pubmed:copyrightInfo(c) 2006 American Cancer Society.lld:pubmed
pubmed-article:16944535pubmed:issnTypePrintlld:pubmed
pubmed-article:16944535pubmed:day1lld:pubmed
pubmed-article:16944535pubmed:volume107lld:pubmed
pubmed-article:16944535pubmed:ownerNLMlld:pubmed
pubmed-article:16944535pubmed:authorsCompleteYlld:pubmed
pubmed-article:16944535pubmed:pagination1511-9lld:pubmed
pubmed-article:16944535pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:meshHeadingpubmed-meshheading:16944535...lld:pubmed
pubmed-article:16944535pubmed:year2006lld:pubmed
pubmed-article:16944535pubmed:articleTitleLysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.lld:pubmed
pubmed-article:16944535pubmed:affiliationGynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.lld:pubmed
pubmed-article:16944535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16944535pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16944535pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16944535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16944535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16944535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16944535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16944535lld:pubmed